Buy this article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this article you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Source:

Nursing2015

October 2005, Volume 35 Number 10 , p 30 - 30

Authors

Abstract

The FDA has approved tigecycline (Tygacil), the first in a new class of drugs called glycylcyclines. This broad-spectrum antibiotic treats complicated intra-abdominal infections and skin and skin structure infections in adults. It's also effective against methicillin-resistant Staphylococcus aureus (MRSA).

To continue reading, buy this article for just $3.95.

Have a coupon or promotional code? Enter it here: